Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?

PLoS Medicine

Volumn 4, Issue 2, 2007, Pages 0226-0228

  Gillim Ross, Laura ^a   Subbarao, Kanta ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; H1N1 INFLUENZA VIRUS DNA VACCINE; HEMAGGLUTININ; INFLUENZA VACCINE; SIALIDASE; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

AVIAN INFLUENZA; CROSS REACTION; DISEASE DURATION; DISEASE SEVERITY; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A H5N1; PANDEMIC; REVIEW; VACCINATION; VIRUS REPLICATION; ENZYMOLOGY; IMMUNITY; IMMUNOLOGY; INFLUENZA VIRUS A H3N2; PATHOGENICITY; PROGNOSIS; VIROLOGY;

ANTIBODIES, VIRAL; HUMANS; IMMUNITY; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; NEURAMINIDASE; PROGNOSIS;

EID: 33847648935     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040091     Document Type: Review

References (15)

1. Powers DC, Kilbourne ED, Johansson BE (1996) Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults. Clin Diagn Lab Immunol 3: 511-516.
2. Kilbourne ED, Laver WG, Schulman JL, Webster RG (1968) Antiviral activity of antiserum specific for an influenza virus neuraminidase. J Virol 2: 281-288.
3. Murphy BR, Kasel JA, Chanock RM (1972) Association of serum anti-neuraminidase antibody with resistance to influenza in man. New Engl J Med 286: 1329-1332.
4. Schulman JL, Khakpour M, Kilbourne ED (1968) Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J Virol 2: 778-786.
5. Chen Z, Yoshikawa T, Kadowaki S, Hagiwara Y, Matsuo K, et al. (1999) Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein. J Gen Virol 80: 2559-2564.
6. Epstein SL, Misplon JA, Lawson CM, Subbarao EK, Connors M, et al. (1993) Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. J Immunol 150: 5484-5493.
7. Chen Z, Kadowaki S, Hagiwara Y, Yoshikawa T, Matsuo K, et al. (2000) Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. Vaccine 18: 3214-3222.
8. Sandbulte MR, Jimenez GS, Boon ACM, Smith LR, Treanor JJ, et al. (2006) Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 4: e59. doi:10.1371/journal.pmed.0040059
9. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, et al. (2006) Strategies for mitigating an influenza pandemic. Nature 442: 448-452.
10. Couch RB, Kasel JA (1983) Immunity to influenza in man. Annu Rev Microbiol 37: 529-549.
11. Hobson D, Curry RL, Beare AS, Ward-Gardner A (1972) The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 70: 767-777.
12. Potter CW, Oxford JS (1979) Determinants of immunity to influenza infection in man. Br Med Bull 35: 69-75.
13. Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M (2006) Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 354: 1343-1351.
14. Treanor JJ, Wilkinson BE, Masseoud F, Hu-Primmer J, Battaglia R, et al. (2001) Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine 19: 1732-1737.
15. Clements ML, Betts RF, Tierney EL, Murphy BR (1986) Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol 24: 157-160.